about
Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.Disease activity return after natalizumab cessation in multiple sclerosis.Natalizumab in relapsing-remitting multiple sclerosis.JCV serology in time: 3 years of follow-up.Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biologicaSystematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis
P2860
Q36314901-2412C2F2-0CF3-4871-9C85-9A05C493370BQ38612977-F7A30369-71BE-4845-A471-95E71A32209FQ38779091-BFCFCC1E-DF01-4D1F-B403-9D5F9977AACAQ38786252-A261BFDD-7471-449E-AE1C-D55484261B91Q39263983-B25AEB2F-F3A4-4221-836A-1E05C6536658Q40067748-37E1622F-152F-4EEC-8E60-153C29B4A852Q47548881-42094976-2DC0-496E-945D-127210700FF2Q58556268-64A5EFD3-1F1B-4A59-AC63-796DB40B4220
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-JC virus seroprevalence in a Finnish MS cohort.
@en
type
label
Anti-JC virus seroprevalence in a Finnish MS cohort.
@en
prefLabel
Anti-JC virus seroprevalence in a Finnish MS cohort.
@en
P2093
P2860
P356
P1476
Anti-JC virus seroprevalence in a Finnish MS cohort
@en
P2093
A Verkkoniemi-Ahola
I Elovaara
K Koivisto
P2860
P304
P356
10.1111/ANE.12475
P407
P577
2015-09-08T00:00:00Z